Successful treatment of a child with MEK inhibitor‐induced acneiform eruption with low‐dose isotretinoin
Sign Up to like & getrecommendations! Published in 2022 at "Pediatric Dermatology"
DOI: 10.1111/pde.14959
Abstract: Selumetinib is a mitogen‐activated protein kinase/extracellular signal‐regulated kinase inhibitor (MEKi) approved to treat inoperable plexiform neurofibromas and used off‐label for low‐grade gliomas. Acneiform eruptions are a known complication of MEKi use, and in some cases,… read more here.
Keywords: isotretinoin; dose isotretinoin; inhibitor; acneiform eruption ... See more keywords